Dimitar G. Efremov

Località Padriciano 99 Street
Trieste, 34149, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

IL-16 drives a novel pathway of BTK inhibitor resistance.

IL-16 drives a novel pathway of BTK inhibitor resistance.

Journal: Blood
Published: September 03, 2026

The biology and evolution of Richter transformation in chronic lymphocytic leukemia.

The biology and evolution of Richter transformation in chronic lymphocytic leukemia.

Journal: Seminars in cancer biology
Published: November 02, 2025

Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study.

Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study.

Journal: Blood advances
Published: March 18, 2025

Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience.

Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience.

Journal: Hematological oncology
Published: December 02, 2024

CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Journal: Blood
Published: November 30, 2024

G-protein coupled receptor kinase-2 regulates the migration of chronic lymphocytic leukaemia cells to sphingosine-1 phosphate in vitro and their trafficking in vivo.

G-protein coupled receptor kinase-2 regulates the migration of chronic lymphocytic leukaemia cells to sphingosine-1 phosphate in vitro and their trafficking in vivo.

Journal: Scientific reports
Published: November 11, 2024

Potassium/sodium cation carriers robustly upregulate CD20 antigen by targeting MYC, and synergize with anti- CD20 immunotherapies to eliminate malignant B cells.

Potassium/sodium cation carriers robustly upregulate CD20 antigen by targeting MYC, and synergize with anti- CD20 immunotherapies to eliminate malignant B cells.

Journal: Haematologica
Published: May 13, 2024

Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome.

Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome.

Journal: Cancers
Published: May 09, 2024

NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia.

NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia.

Journal: Leukemia
Published: November 09, 2023

A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome.

A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome.

Journal: Blood advances
Published: September 14, 2023

T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

Journal: Blood
Published: July 31, 2023

Editorial: The notch signaling pathway in lymphoid malignancies.

Editorial: The notch signaling pathway in lymphoid malignancies.

Journal: Frontiers in oncology
Published: May 03, 2023
Showing 1-12 of 73

Last Updated: 09/26/2026